Editorial: Cardiac Remodeling: New Insights in Physiological and Pathological Adaptations.
作者信息
Roever Leonardo, Palandri Chagas Antonio C
机构信息
Federal University of Uberlândia, Uberlândia, Brazil.
Heart Institute (InCor), HCFMUSP University of São Paulo Medical School, São Paulo, Brazil.
出版信息
Front Physiol. 2017 Sep 26;8:751. doi: 10.3389/fphys.2017.00751. eCollection 2017.
Abstract
摘要
相似文献
1
Editorial: Cardiac Remodeling: New Insights in Physiological and Pathological Adaptations.社论：心脏重塑：生理和病理适应方面的新见解
Front Physiol. 2017 Sep 26;8:751. doi: 10.3389/fphys.2017.00751. eCollection 2017.
2
Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.内皮叉头框转录因子 P1 通过转化生长因子-β1-内皮素-1 信号通路调节病理性心脏重构。
Circulation. 2019 Aug 20;140(8):665-680. doi: 10.1161/CIRCULATIONAHA.119.039767. Epub 2019 Jun 10.
3
The fibrosis-cell death axis in heart failure.心力衰竭中的纤维化-细胞死亡轴
Heart Fail Rev. 2016 Mar;21(2):199-211. doi: 10.1007/s10741-016-9536-9.
4
Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.长春西汀通过抑制心肌肥大和纤维化减轻病理性心脏重塑。
Cardiovasc Drugs Ther. 2017 Apr;31(2):157-166. doi: 10.1007/s10557-017-6719-0.
5
Mechanisms contributing to cardiac remodelling.导致心脏重构的机制。
Clin Sci (Lond). 2017 Aug 24;131(18):2319-2345. doi: 10.1042/CS20171167. Print 2017 Sep 15.
6
Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury.Tomo-Seq 鉴定 Sox9 为缺血性损伤中心脏纤维化的关键调节因子。
Circulation. 2017 Oct 10;136(15):1396-1409. doi: 10.1161/CIRCULATIONAHA.117.027832. Epub 2017 Jul 19.
7
Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies.生理和病理性心脏重构模型中的独特脂质组学特征，以及潜在的治疗策略。
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Mar;1863(3):219-234. doi: 10.1016/j.bbalip.2017.12.003. Epub 2017 Dec 6.
8
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.心脏重塑发生与进展的分子机制综述
Oxid Med Cell Longev. 2017;2017:3920195. doi: 10.1155/2017/3920195. Epub 2017 Jul 2.
9
Excessive training induces molecular signs of pathologic cardiac hypertrophy.过度训练会引起病理性心肌肥厚的分子标志。
J Cell Physiol. 2018 Nov;233(11):8850-8861. doi: 10.1002/jcp.26799. Epub 2018 May 24.
10
Cardiac damage in athlete's heart: When the "supernormal" heart fails!运动员心脏的心脏损伤：当“超常”心脏衰竭时！
World J Cardiol. 2017 Jun 26;9(6):470-480. doi: 10.4330/wjc.v9.i6.470.
引用本文的文献
1
Comprehensive Insights into Mechanisms for Ventricular Remodeling in Right Heart Failure.右心衰竭心室重塑机制的综合见解
Rev Cardiovasc Med. 2024 Nov 29;25(12):426. doi: 10.31083/j.rcm2512426. eCollection 2024 Dec.
2
Anshen Shumai Decoction inhibits post-infarction inflammation and myocardial remodeling through suppression of the p38 MAPK/c-FOS/EGR1 pathway.安神舒心汤通过抑制 p38 MAPK/c-FOS/EGR1 通路抑制梗死后炎症和心肌重构。
J Mol Histol. 2024 Aug;55(4):437-454. doi: 10.1007/s10735-024-10214-4. Epub 2024 Jun 14.
3
The Influence of Special Military Training on Left Ventricular Adaptation to Exercise in Elite Air Force Soldiers.特种军事训练对精英空军士兵左心室运动适应性的影响。
J Cardiovasc Echogr. 2023 Apr-Jun;33(2):69-75. doi: 10.4103/jcecho.jcecho_67_22. Epub 2023 Aug 14.
4
Peiminine inhibits myocardial injury and fibrosis after myocardial infarction in rats by regulating mitogen-activated protein kinase pathway.浙贝母碱通过调节丝裂原活化蛋白激酶信号通路抑制大鼠心肌梗死后的心肌损伤和纤维化。
Korean J Physiol Pharmacol. 2022 Mar 1;26(2):87-94. doi: 10.4196/kjpp.2022.26.2.87.
5
T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies.在恰加斯病与特发性扩张型心肌病中，T细胞亚群表现出不同的募集潜力、免疫调节特征和功能特性。
Front Cardiovasc Med. 2022 Feb 2;9:787423. doi: 10.3389/fcvm.2022.787423. eCollection 2022.
6
Between Inflammation and Autophagy: The Role of Leptin-Adiponectin Axis in Cardiac Remodeling.炎症与自噬之间：瘦素 - 脂联素轴在心脏重塑中的作用
J Inflamm Res. 2021 Oct 16;14:5349-5365. doi: 10.2147/JIR.S322231. eCollection 2021.
7
Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome.辅酶Q10可能通过降低急性冠脉综合征患者的血管紧张素转换酶来调节重塑。
Antioxidants (Basel). 2018 Jul 25;7(8):99. doi: 10.3390/antiox7080099.
本文引用的文献
1
The Role for Cardiovascular Remodeling in Cardiovascular Outcomes.心血管重塑在心血管结局中的作用。
Curr Atheroscler Rep. 2017 May;19(5):23. doi: 10.1007/s11883-017-0656-z.
2
An update on technical and methodological aspects for cardiac PET applications.心脏正电子发射断层显像（PET）应用的技术与方法学进展
Q J Nucl Med Mol Imaging. 2016 Dec;60(4):285-307. Epub 2016 Sep 9.
3
Autophagy during cardiac remodeling.心脏重塑过程中的自噬
J Mol Cell Cardiol. 2016 Jun;95:11-8. doi: 10.1016/j.yjmcc.2015.12.003. Epub 2015 Dec 8.
4
Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment.心脏重塑：概念、临床影响、病理生理机制及药物治疗
Arq Bras Cardiol. 2016 Jan;106(1):62-9. doi: 10.5935/abc.20160005. Epub 2015 Dec 8.
5
Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.氧化应激在收缩性和舒张性心力衰竭中的病理生理作用及其治疗意义。
Eur Heart J. 2015 Oct 7;36(38):2555-64. doi: 10.1093/eurheartj/ehv305. Epub 2015 Jul 4.
6
Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.循环心肌纤维化生物标志物：重新评估的必要性。
J Am Coll Cardiol. 2015 Jun 9;65(22):2449-56. doi: 10.1016/j.jacc.2015.04.026.
7
miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.微小RNA-222对于运动诱导的心脏生长是必需的，并可防止病理性心脏重塑。
Cell Metab. 2015 Apr 7;21(4):584-95. doi: 10.1016/j.cmet.2015.02.014.
8
Getting to the heart of the matter: new insights into cardiac fibrosis.直击问题核心：心脏纤维化的新见解。
Circ Res. 2015 Mar 27;116(7):1269-76. doi: 10.1161/CIRCRESAHA.116.305381.
9
How cardiomyocyte excitation, calcium release and contraction become altered with age.心肌细胞的兴奋、钙释放和收缩如何随年龄而改变。
J Mol Cell Cardiol. 2015 Jun;83:62-72. doi: 10.1016/j.yjmcc.2014.12.004. Epub 2014 Dec 10.
10
The role of lipotoxicity in smoke cardiomyopathy.脂毒性在烟雾性心肌病中的作用。
PLoS One. 2014 Dec 2;9(12):e113739. doi: 10.1371/journal.pone.0113739. eCollection 2014.
Zotero 插件